Abstract:Neuronal excitatory synapses are primarily located on small dendritic protrusions called spines. During synaptic plasticity underlying learning and memory, Ca2+ influx through postsynaptic NMDA-type glutamate receptors (NMDARs) initiates signaling pathways that coordinate changes in dendritic spine structure and synaptic function. During long-term potentiation (LTP), high levels of NMDAR Ca2+ influx promote increases in both synaptic strength and dendritic spine size through activation of Ca2+-dependent protein kinases. In contrast, during long-term depression (LTD), low levels of NMDAR Ca2+ influx promote decreased synaptic strength and spine shrinkage and elimination through activation of the Ca2+-dependent protein phosphatase calcineurin (CaN), which is anchored at synapses via the scaffold protein A-kinase anchoring protein (AKAP)150. In Alzheimer's disease (AD) the pathological agent amyloid-β (Aβ) may impair learning and memory through biasing NMDAR Ca2+ signaling pathways toward LTD and spine elimination. By employing AKAP150 knock-in mice of both sexes with a mutation that disrupts CaN anchoring to AKAP150, we revealed that local, postsynaptic AKAP-CaN-LTD signaling was required for Aβ-mediated impairment of NMDAR synaptic Ca2+ influx, inhibition of LTP, and dendritic spine loss. Additionally, we found that Aβ acutely engages AKAP-CaN signaling through activation of G protein-coupled metabotropic glutamate receptor 1 (mGluR1) leading to dephosphorylation of NMDAR-GluN2B subunits, which decreases Ca2+ influx to favor LTD over LTP, and cofilin, which promotes F-actin severing to destabilize dendritic spines. These findings reveal a novel interplay between NMDAR and mGluR1 signaling that converges on AKAP-anchored CaN to coordinate dephosphorylation of postsynaptic substrates linked to multiple aspects of Aβ-mediated synaptic dysfunction.Significance Statement Understanding mechanisms of synaptic dysfunction in Alzheimer's disease (AD) is pivotal for therapeutic advances. Amyloid-β oligomers (Aβo), primary culprits in AD pathology, disrupt critical synaptic plasticity mechanisms, leading to enhanced LTD and synaptic loss. However, the underlying signaling pathways remain elusive. Calcineurin (CaN), localized by AKAP79/150 at synapses, plays a key role in LTD formation. Inhibition of CaN mitigates Aβo-induced synaptic deficits, implicating its involvement in AD pathology. Our study shows that AKAP-anchored CaN is critical in acute Aβo-mediated inhibition of NMDAR Ca2+ signaling and dendritic spine loss. Additionally, we identify mGluR1 as an upstream regulator of these Aβo-induced deficits, highlighting several potential therapeutic targets for AD-related synaptic pathology.

Oligomerized Abeta25-35 induces increased tyrosine phosphorylation of NMDA receptor subunit 2A in rat hippocampal CA1 subfield.

Oligomerized Aβ25–35 induces increased tyrosine phosphorylation of NMDA receptor subunit 2A in rat hippocampal CA1 subfield

Involvement of P38MAPK Activation by NMDA Receptors and Non-Nmda Receptors in Amyloid-Β Peptide-Induced Neuronal Loss in Rat Hippocampal CA1 and CA3 Subfields

Differential Regulation of N-Methyl-D-Aspartate Receptor Subunits is an Early Event in the Actions of Soluble Amyloid-β(1-40) Oligomers on Hippocampal Neurons.

P2X receptor overexpression induced by soluble oligomers of amyloid beta peptide potentiates synaptic failure and neuronal dyshomeostasis in cellular models of Alzheimer's disease

Amyloid-β Induces Caspase-Dependent Loss of PSD-95 and Synaptophysin Through NMDA Receptors

MLK3‐MKK3/6‐P38MAPK Cascades Following N‐methyl‐D‐aspartate Receptor Activation Contributes to Amyloid‐β Peptide‐induced Apoptosis in SH‐SY5Y Cells

Amyloid Β Oligomers Suppress Excitatory Transmitter Release Via Presynaptic Depletion of Phosphatidylinositol-4,5-bisphosphate

Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease

P1‐210: DAPK1 IS REQUIRED FOR THE EARLY NEURONAL DAMAGE AND COGNITIVE IMPAIRMENT INDUCED BY Aβ OLIGOMERS

EFFECTS OF NMDA RECEPTORS IN SYNAPSE AND EXTRASYNAPSE OF RAT HIPPOCAMPAL NEURONS ON THE EXPRESSION OF POSTSYNAPTIC DENSITY-95 INDUCED BY AMYLOID-BETA

Linking activation of synaptic NMDA receptors‐induced CREB signaling to brief exposure of cortical neurons to oligomeric amyloid‐beta peptide

A Beta-Mediated Nmda Receptor Endocytosis In Alzheimer'S Disease Involves Ubiquitination Of The Tyrosine Phosphatase Step61

Oligomeric Aβ-induced Synaptic Dysfunction in Alzheimer’s Disease

Effects of NMDA receptors on amyloid-beta induced alteration of synaptic proteins in hippocampal neurons

Amyloid-β causes NMDA receptor dysfunction and dendritic spine loss through mGluR1 and AKAP150-anchored calcineurin signaling

Role of Norepinephrine in Aβ-related Neurotoxicity: Dual Interactions with Tyr10 and SNK(26-28) of Aβ.

β-Amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3

A Brief Ischemic Postconditioning Protects Against Amyloid-β Peptide Neurotoxicity by Downregulating MLK3-MKK3/6-P38MAPK Signal in Rat Hippocampus.

Adverse Effects of Aβ1-42 Oligomers: Impaired Contextual Memory and Altered Intrinsic Properties of CA1 Pyramidal Neurons

Aβ1-42 oligomers induced a short-term increase of glutamate release prior to its depletion as measured by amperometry on single varicosities.